FO
FT Options Portfolio holdings
AUM
$40M
This Quarter Return
+7.66%
1 Year Return
+13.03%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$101M
AUM Growth
–
Cap. Flow
+$101M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
51.34%
Holding
88
New
73
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Gilead Sciences
GILD
|
$12.7M |
| 2 |
CELG
Celgene Corp
CELG
|
$6.57M |
| 3 |
Chipotle Mexican Grill
CMG
|
$6.44M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$6.35M |
| 5 |
Abbott
ABT
|
$5.49M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 58.06% |
| 2 | Consumer Discretionary | 8.21% |
| 3 | Materials | 5.13% |
| 4 | Consumer Staples | 4.96% |
| 5 | Technology | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Coca-Cola Europacific Partners
CCEP
$40.4B
| $1.21M | 0.89% |
+24,600
| New | +$1.21M |
|
27
Dynavax Technologies
DVAX
$1.19B
| $1.14M | 0.84% |
+47,248
| New | +$1.14M |
|
|
YHOO
28
DELISTED
Yahoo Inc
YHOO
| $1.12M | 0.83% |
+33,741
| New | +$1.12M |
|
29
Synchrony
SYF
$28.4B
| $1.1M | 0.81% |
+36,033
| New | +$1.1M |
|
|
ALXN
30
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.09M | 0.8% |
+5,687
| New | +$1.09M |
|
31
AT&T
T
$209B
| $1.03M | 0.76% |
+29,895
| New | +$1.03M |
|
32
Broadcom
AVGO
$1.4T
| $962K | 0.71% |
+6,626
| New | +$962K |
|
33
Insperity
NSP
$2.08B
| $932K | 0.69% |
+19,354
| New | +$932K |
|
|
SYT
34
DELISTED
Syngenta Ag
SYT
| $810K | 0.6% |
+10,294
| New | +$810K |
|
|
HOT
35
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $797K | 0.59% |
+11,500
| New | +$797K |
|
36
Precigen
PGEN
$1.34B
| $725K | 0.53% |
+24,049
| New | +$725K |
|
|
GMCR
37
DELISTED
KEURIG GREEN MTN INC
GMCR
| $694K | 0.51% |
+7,710
| New | +$694K |
|
|
CASC
38
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $666K | 0.49% |
+300,011
| New | +$666K |
|
|
BLUE
39
DELISTED
bluebird bio
BLUE
| $644K | 0.48% |
+10,021
| New | +$644K |
|
|
BHI
40
DELISTED
Baker Hughes
BHI
| $603K | 0.44% |
+13,066
| New | +$603K |
|
|
AEGR
41
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $590K | 0.44% |
+58,445
| New | +$590K |
|
42
Pfizer
PFE
$141B
| $583K | 0.43% |
+18,070
| New | +$583K |
|
|
TIF
43
DELISTED
Tiffany & Co.
TIF
| $544K | 0.4% |
+7,129
| New | +$544K |
|
44
Larimar Therapeutics
LRMR
$310M
| $502K | 0.37% |
+79,780
| New | +$502K |
|
45
Akebia Therapeutics
AKBA
$833M
| $467K | 0.34% |
+36,156
| New | +$467K |
|
46
AB InBev
BUD
$122B
| $463K | 0.34% |
+3,700
| New | +$463K |
|
47
Qualcomm
QCOM
$173B
| $460K | 0.34% |
+9,200
| New | +$460K |
|
|
FPRX
48
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $436K | 0.32% |
+10,505
| New | +$436K |
|
49
BioCryst Pharmaceuticals
BCRX
$1.74B
| $409K | 0.3% |
+39,600
| New | +$409K |
|
|
CLVS
50
DELISTED
Clovis Oncology, Inc.
CLVS
| $338K | 0.25% |
+9,660
| New | +$338K |
|